Alira Health

Alira Health

Market Access: MedTech

Market Access Diagnostic MAP™

Focused solutions designed for commercial success

Your Alira Health can provide you with a range of solutions, all focused on three key areas:

Messaging

  • Diagnostic of existing tools to support a structured value framework
  • Cross-functional workshops to align product and commercial teams to domains of value
  • Gap assessment of evidence
  • Pricing analysis deep dive and objectives

Activity

  • Diagnostic of country stakeholder maps and gap analysis for key geographies
  • Regional payer segmentation and local provider engagement assessment
  • Alignment on external activity cadence

Process

  • Unmet need and patient pathway creation
  • Reimbursement and procurement approval
  • Clinical and economic KOL mapping
  • Clinical and economic evidence strategy
  • Centre specific pilot programs
  • Value-based access programs
  • HCP access and user training
  • Clinical and economic advocacy
  • Optimization of clinical and payer guidelines

Why choose Alira Health?

As your partner, we’ll work closely with you to uncover opportunities across the pharma industry, accelerate innovation, and deliver tomorrow’s standard of care. You’ll benefit from our:

  • Access to a diverse

    integrated team with deep industry expertise

  • Close collaboration

    with our regulatory and clinical

  • Specific, local insights

    as part of your larger, global strategy—a benefit of having market access teams in both the EU and U.S.

Working together to transform healthcare

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Contact us
Richard Charter
Richard Charter
Vice President, Market Access, MedTech, Europe and Asia-Pacific
Our holistic, lifecycle approach to market access provides clients with maximum clinical and economic value for their technology while supporting patient-centered, value-based healthcare.

Related News

Reports May 20, 2024
Innovative Payment Schemes for Medtech in England, Germany, and France
This overview offers high-level details on the innovative payment schemes in England, Germany, and France.
MedTech
Case Studies May 14, 2024
Medtech Company Creates an Early Go-to-Market Strategy for Its Breakthrough IVD Solution
The client needed an early go-to-market strategy for their IVD solution to prepare for product development and launch in key European countries and the US.
IVDR Medical Devices MedTech
Case Studies May 8, 2024
Mid-Size Medtech Company with a Borderline Product Defines Strategy for EU Launch
Medtech company sought support in developing a regulatory strategy for the EU launch of their product with an aggressive timeline to launch.
Medical Devices MedTech Regulatory
Reports May 8, 2024
Value-Based Procurement in Australia
This white paper discusses why value-based healthcare and procurement are solutions in a robust healthcare system and identifies the medical technology sector as a collaborative partner(...)
MedTech Value-Based Contracts
Case Studies April 30, 2024
Medtech Company Leverages Bayesian Clinical Trial Design to Address FDA Feedback
A global medtech company needed help to address FDA feedback on their implant design that included a comparator and clearly demonstrated the safety and performance of this new device.
Clinical Trials Complex Innovative Design MedTech
Events April 30, 2024
The MedTech Forum 2024
We are thrilled to announce that we will exhibit and speak at The MedTech Forum 2024.
MedTech Regulatory
News April 29, 2024
Alira Health Advises Trill Impact Entering a Strategic Alliance with TT medic
We are pleased to have been a Commercial Due Diligence advisor for Trill Impact, a pioneering Impact House with around EUR 1.2 billion in assets under management, joining forces with(...)
CDD CDMO MedTech
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.